Atıf İçin Kopyala
Link M. S., Giugliano R. P., Ruff C. T., Scirica B. M., Huikuri H., Oto A., ...Daha Fazla
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, cilt.10, sa.1, 2017 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
10
Sayı:
1
-
Basım Tarihi:
2017
-
Doi Numarası:
10.1161/circep.116.004267
-
Dergi Adı:
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Anahtar Kelimeler:
atrial fibrillation, bleeding, mortality, stroke, thromboembolism, ASSOCIATION TASK-FORCE, AMERICAN-COLLEGE, WARFARIN, MANAGEMENT, COLLABORATION, PERSISTENT, GUIDELINES, EDOXABAN, UPDATE
-
Gazi Üniversitesi Adresli:
Evet
Özet
Background-Whether the pattern of atrial fibrillation (AF) modifies the risk/benefit of anticoagulation is controversial. In ENGAGE AF-TIMI 48 trial (Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48), the factor Xa inhibitor edoxaban was noninferior to warfarin in preventing stroke or systemic embolic events and significantly reduced bleeding and cardiovascular mortality. However, detailed analyses by AF pattern have not been reported.